Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNX-1300 for Acute Cocaine Intoxication
NCT04996056Phase 2Withdrawn
- Sponsor
- Tonix Pharmaceuticals
- Start
- Sep 2021
- Primary completion
- Jun 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TNX-1300 in cocaine intoxication, sponsored by Tonix Pharmaceuticals. Planned start Sep 2021; status: withdrawn.
02
Drugs
TNX-1300
03
Conditions
cocaine intoxication
Beyond the preview
Go deeper on NCT04996056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996056.